Clinical Trials in Baltimore

Showing 2421-2440 of 23,476 trials

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

NCT03152318

This research study is evaluating an investigational drug, an oncolytic virus called rQNestin34.5v.2. This research study is a Phase I clinical trial, which tests the safety of an investigational drug and also tries to define the appropriate dose of the investigational drug as a possible treatment for this diagnosis of recurrent or progressive brain tumor.

Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more

Dana-Farber Cancer Institute62 participantsStarted Jul 2017

Baltimore, Maryland, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

Active Not Recruiting< 1 mile

Rate of Progression in EYS Related Retinal Degeneration

NCT04127006

The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with EYS mutations in order to accelerate the development of outcome measures for clinical trials.

Retinitis PigmentosaEye Diseases

Jaeb Center for Health Research103 participantsStarted Feb 2020

San Francisco, California, United States • Denver, Colorado, United States • Gainesville, Florida, United States +16 more locations

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Rate of Progression in EYS Related Retinal Degeneration

Find Trials by Condition in Baltimore

The Protrieve PROTECTOR Study

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

The Radiation Oncology Registry and Biosample Repository

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)

Avexitide for Treatment of Post-Bariatric Hypoglycemia

Otoferlin Gene-mediated Hearing Loss Natural History Study

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

Distance-Based Exercise to Preserve Function and Prevent Disability

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)

Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness